Recombinant Human LH alpha/beta Heterodimer Protein

Carrier Free

Catalog # Availability Size / Price Qty
8899-LH-010/CF

With Carrier

Catalog # Availability Size / Price Qty
8899-LH-010
Best Seller
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (1)
FAQs
Reviews

Recombinant Human LH alpha/beta Heterodimer Protein Summary

Product Specifications

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to induce cAMP accumulation in MLTC‑1 mouse Leydig tumor cells. Rebois, R.V. et al. (1982) J. Cell Biol. 94:70. The ED50 for this effect is 0.075-0.75 ng/mL.
Source
Chinese Hamster Ovary cell line, CHO-derived human LH alpha/beta Heterodimer protein
Ala25-Ser116 ( alpha chain) & Ser21-Leu141 ( beta chain)
N-terminal Sequence
Analysis
Ala25 ( alpha chain), Ser21 ( beta chain)
Structure / Form
Non-covalent heterodimer
Predicted Molecular Mass
10 kDa ( alpha chain), 13 kDa ( beta chain)
SDS-PAGE
15-26 kDa, reducing conditions

Product Datasheets

You must select a language.

x

8899-LH (with carrier)

You must select a language.

x

8899-LH/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

8899-LH

Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

8899-LH/CF

Formulation Lyophilized from a 0.2 μm filtered solution in sterile PBS.
Reconstitution Reconstitute at 100 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: LH alpha/beta Heterodimer

Luteinizing Hormone (LH) is a 42 kDa heterodimer belonging to the glycoprotein hormone family. It is composed of noncovalently linked glycosylated alpha  and beta  chains. The alpha  subunit (CG alpha ) is also a component of Follicle-Stimulating Hormone (FSH), Thyroid-Stimulating Hormone, and Chorionic Gonadotropin. The unique beta  subunit confers the protein’s specific biological action and is responsible for the interaction with its receptor (1, 2). The approximately 20 kDa human CG alpha subunit shares 73% and 72% amino acid (aa) sequence identity with the mouse and rat orthologs, respectively. The approximately 18 kDa human LH beta subunit shares 71% and 72% aa sequence identity with the mouse and rat orthologs, respectively. Multiple isoforms of LH exist due to differences in the post-translational glycosylation, sialylation, and sulphation modifications of its subunits (3-6). The composition, longevity, and activity of the different LH isoforms vary throughout a woman’s menstrual cycle and reproductive life cycle (7). LH is produced and secreted by the anterior pituitary gland. Its secretion is controlled by Gonadotropin-Releasing Hormone from the hypothalamus; however, LH secretion can also be stimulated by estradiol (7, 8). LH works in concert with FSH to regulate female reproduction; FSH stimulates follicular growth and LH induces ovulation (9). LH also drives formation of the corpus luteum by promoting progesterone production (7). Additionally, LH has been suggested to stimulate the adrenal gland in postmenopausal women to induce secretion of sulfated DHEA, a precursor to androgens (10, 11). In the testis, LH induces Leydig cell production of testosterone (7). Hypersecretion of LH has been shown to occur in women with polycystic ovary syndrome and is associated with an increased risk of infertility and miscarriage (12, 13). Additionally, increased serum LH levels are associated with decreased cognition and have been implicated in the development and progression of Alzheimer’s disease (14, 15).

References
  1. Keutmann, H.T. et al. (1987) Proc. Natl. Acad. Sci. USA 84:2038.
  2. Keutmann, H.T. et al. (1992) Mol. Endocrinol. 6:904.
  3. Wilson, C.A. et al. (1990) J. Endocrinol. 125:3.
  4. Stanton, P.G. et al. (1993) J. Endocrinol. 138:529.
  5. Stanton, P.G. et al. (1996) Mol. Cell. Endocrinol. 125:133.
  6. Bergendah, M. and J.D. Veldhuis (2001) Hum. Reprod. 16:1058.
  7. Choi, J. and J. Smitz (2014) Mol. Cell. Endocrinol. 383:203.
  8. Marshall, J.C. et al. (1993) Trans. Am. Clin. Climatol. Assoc. 104:31.
  9. Raju, G.A. et al. (2013) J. Hum. Reprod. Sci. 6:227.
  10. Alevizaki, M. et al. (2006) Eur. J. Endocrinol. 154:875.
  11. Moran, F.M. et al. (2013) Menopause 20:329.
  12. Balen, A.H. (1995) J. R. Soc. Med. 88:339P.
  13. Blank, S.K. et al. (2006) Hum. Reprod. Update 12:351.
  14. Webber, K.M. et al. (2007) Clin. Med. Res. 5:177.
  15. Blair, J.A. et al. (2015) Front. Endocrinol. (Lausanne) 6:45.
Long Name
Luteinizing Hormone alpha/beta Heterodimer
Alternate Names
LH alpha/beta Heterodimer

Citation for Recombinant Human LH alpha/beta Heterodimer Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

1 Citation: Showing 1 - 1

  1. A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer
    Authors: W Marlicz, A Poniewiers, S Rzeszotek, R Bartoszews, K Skonieczna, T Starzy?ska, MZ Ratajczak
    PLoS ONE, 2018-03-01;13(3):e0189337.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human LH alpha/beta Heterodimer Protein

There are currently no reviews for this product. Be the first to review Recombinant Human LH alpha/beta Heterodimer Protein and earn rewards!

Have you used Recombinant Human LH alpha/beta Heterodimer Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review